Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Wraps up $260M Fermentas Acquisition

Premium

This story was originally published on July 16.

Thermo Fisher Scientific said today after the markets closed that it has completed its previously announced $260 million acquisition of Fermentas.

Thermo Fisher first announced its intent to acquire Fermentas in May. The deal is expected to bolster Thermo's capabilities in PCR and quantitative real-time PCR (PCR Insider, 5/27/10).

Fermentas, which is headquartered in Burlington, Ontario, and has principal operations in Vilnius, Lithuania, also provides a broad range of molecular and cellular biology research products, including reagents for nucleic acid and protein purification, restriction and modifying enzymes, molecular weight markers, and other research and diagnostic tools.

Fermentas has approximately 500 employees and had full-year revenues of approximately C$57 million in 2009 (approximately $55 million). The company will be integrated into Thermo Fisher’s Analytical Technologies segment.

In a statement, Thermo said that Fermentas’ "broad range of high-quality molecular and cellular biology research tools, including reagents, enzymes, and kits" will help Thermo to offer a "complete workflow for genomics research while building on its platform of PCR and qPCR tools and resources."

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.